{"symbol": "FOMX", "companyName": "Foamix Pharmaceuticals Ltd.", "exchange": "NASDAQ Global Market", "industry": "Biotechnology", "website": "http://www.foamixpharma.com", "description": "Foamix Pharmaceuticals Ltd is a clinical-stage specialty pharmaceutical company. It is engaged in developing and commercializing minocycline foam for the treatment of acne, rosacea, impetigo and other skin conditions. Its products include FMX101 & FMX103.", "CEO": "David Domzalski", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}